{
    "2019-06-13": [
        [
            {
                "time": "2019-06-13",
                "original_text": "The Opioid Epidemic Will Be A Yearslong Overhang For These Pharma Stocks",
                "features": {
                    "keywords": [
                        "opioid epidemic",
                        "pharma stocks",
                        "yearslong overhang"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-13",
                "original_text": "Johnson & Johnson Made the Right Call in Fighting Oklahoma Over Opioids, Analyst Says",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "opioids",
                        "fighting Oklahoma",
                        "analyst says"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-13",
                "original_text": "Health Care Sector Update for 06/13/2019: SVRA, TNXP, PRVB, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "health care sector",
                        "SVRA",
                        "TNXP",
                        "PRVB",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-14",
                "original_text": "Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 14, 2019",
                "features": {
                    "keywords": [
                        "Merck",
                        "ex-dividend date",
                        "June 14, 2019"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-13",
                "original_text": "Market Morning: Huawei Strikes Back, ‘No’ on No No Deal, Ancient Chinese Stoners, Crowded CrowdStrike",
                "features": {
                    "keywords": [
                        "Huawei",
                        "strikes back",
                        "no deal",
                        "Chinese stoners",
                        "CrowdStrike"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology",
                        "international trade"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-13",
                "original_text": "Johnson & Johnson and Cisco Directors Are Buying Up Stock",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Cisco",
                        "directors buying stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}